Search research articles
Contact Us
Filters
Showing results (301-310 of 350) with videos related to
Page
of 35
Sort By:
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
Sylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials
Matthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
JAMA
|
January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
The New England Journal of Medicine
|
June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Annals of Internal Medicine
|
July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial
Caleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Open Forum Infectious Diseases
|
August 25, 2023
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial
Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, et al.
Wellcome Open Research
|
October 22, 2020
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Suzaan Marais, Fiona V Cresswell, Raph L Hamers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 17, 2020
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 350) with videos related to
Sort By:
Page
of 35
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|
May 9, 2020
Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
Sylvain A Lother, Mahsa Abassi, Alyssa Agostinis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical Trials
Matthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
JAMA
|
January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
The New England Journal of Medicine
|
June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Annals of Internal Medicine
|
July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial
Caleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Open Forum Infectious Diseases
|
August 25, 2023
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial
Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, et al.
Wellcome Open Research
|
October 22, 2020
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Suzaan Marais, Fiona V Cresswell, Raph L Hamers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 17, 2020
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Page
of 35